Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by GreenInPIayon Sep 17, 2018 12:39pm
243 Views
Post# 28632844

KALY Therapeutics (KALY) – Ready For liftoff! MultiBagger Op

KALY Therapeutics (KALY) – Ready For liftoff! MultiBagger OpBeen a while since I last posted but waited for the next Huge Opportunity to make some Coin.

Will be the next big Cannabis stock on the Venture. Will BLOW TODAY

Big unjustified sell off after the Trade Resumption (Kaly informed no material changes).

At 10.5 to 11 cents this could break bigtime after the wall comes down at 12 Cents. Could get into Mid to High teens by days end.

Keep this one on your radar today!!

Lots of Buyers lined up and trying to get in on the action on the cheap!
 
BIDS:
0.090 – 1527 (28)
0.095 – 815 (14)
0.100 – 2298 (41)
0.105 – 1462 (26)
 
Asks:
0.115 – 689 (9)
0.120 – 1554 (17)
0.125 – 363 (11)
0.130 – 675 (11)
0.135 – 421 (11)
0.140 – 220 (3)
0.145 – 116 (2)
Bullboard Posts